Presentations
Presentations
Oral presentations
Role of AI in Peripheral T-cell Lymphoma Patient Care
Role of AI in Peripheral T-cell Lymphoma Patient Care
Devavrat Shah
Devavrat Shah
Future Direction of PETAL Consortium
Future Direction of PETAL Consortium
Salvia Jain
Salvia Jain
HOPE-PTCL Portal
HOPE-PTCL Portal
Christina Poh
Christina Poh
Clinical Research Initiatives of PETAL Consortium
Clinical Research Initiatives of PETAL Consortium
Kristiana Nasto
Kristiana Nasto
Molecular Residual Disease in Peripheral T-cell Lymphoma Undergoing Autologous Stem Cell Transplant
Molecular Residual Disease in Peripheral T-cell Lymphoma Undergoing Autologous Stem Cell Transplant
Kusha Chopra
Kusha Chopra
Extranodal Natural Killer/T-cell Lymphoma Multi-omics
Extranodal Natural Killer/T-cell Lymphoma Multi-omics
Alex Lenart
Alex Lenart
Super-enhancers Landscape
Super-enhancers Landscape
Makoto Iwasaki
Makoto Iwasaki
Early time-to-relapse as a survival prognosticator in nodal mature T-cell lymphomas
Early time-to-relapse as a survival
prognosticator in nodal mature
T-cell lymphomas
Early time-to-relapse as a survival prognosticator in nodal mature T-cell lymphomas
Mark Sorial
Mark Sorial
Mark Sorial
Is There a Role for MRD in Predicting Outcome Post Transplant?
Presented by Dr. Salvia Jain.
Is There a Role for MRD in Predicting
Outcome Post Transplant?
Presented by Dr. Salvia Jain.
Dr Salvia Jain
Dr Salvia Jain
PETAL Consortium: Transforming the T-cell Lymphoma Research Landscape
Presented by Forum Bhanushali
PETAL Consortium: Transforming the
Tc-Cell Lymphoma Research
Landscape
Presented by Forum Bhanushali
Forum Bhanushali
Integrative Analysis of Histone Modifications and 3D Chromatin Organization Reveals Altered Epigenetic Landscapes across T-Cell Lymphoma Subtypes Presented by Caroline MacVicar
Integrative Analysis of Histone
Modifications and 3D Chromatin
Organization Reveals Altered
Epigenetic Landscapes across
T-Cell Lymphoma Subtypes
Presented by Caroline MacVicar
Integrative Analysis of Histone Modifications and 3D Chromatin Organization Reveals Altered Epigenetic Landscapes across T-Cell Lymphoma Subtypes Presented by Caroline MacVicar
Caroline MacVicar
Development of a Novel Prognostic Score for Relapsed/Refractory Mature T-Cell and NK-Cell Lymphomas (PIRT): Results from a Global Peripheral T-Cell Lymphoma (PETAL) Consortium
Development of a Novel Prognostic Score
for Relapsed/Refractory Mature T-Cell
and NK-Cell Lymphomas (PIRT):
Results from a Global Peripheral
T-Cell Lymphoma (PETAL) Consortium
Development of a Novel Prognostic Score for Relapsed/Refractory Mature T-Cell and NK-Cell Lymphomas (PIRT): Results from a Global Peripheral T-Cell Lymphoma (PETAL) Consortium
Angela Koh
B. Poster presentations
Unveiling the Tumor Microenvironment in Extranodal NK/T-Cell Lymphoma (ENKTCL) Patients with in Situ Spatial Transcriptomics
Unveiling the Tumor Microenvironment
in Extranodal NK/T-Cell Lymphoma
(ENKTCL) Patients with in Situ Spatial Transcriptomics
Unveiling the Tumor Microenvironment in Extranodal NK/T-Cell Lymphoma (ENKTCL) Patients with in Situ Spatial Transcriptomics
Dimitra Karagkouni
Real-World Evidence for Duvelisib and Romidepsin Combination in Patients with Relapsed/Refractory Peripheral T-Cell Lymphomas
Josie Ford
Integrative Analysis of 3D Chromatin Organization Revealed Regulation Mechanisms in Angioimmunoblastic T-Cell Lymphoma
Integrative Analysis of 3D Chromatin Organization Revealed Regulation
Mechanisms in Angioimmunoblastic
T-Cell Lymphoma
Makoto Iwasaki
Integrated Omics to Dissect the Landscape in Chemosensitive and Refractory Extranodal Natural-Killer T-Cell Lymphoma (ENKTCL): A Global Study of the PETAL (Peripheral T-Cell Lymphoma)Consortium
Presented by Alexandra Lenart
Integrated Omics to Dissect the
Landscape in Chemosensitive and
Refractory Extranodal Natural-Killer
T-Cell Lymphoma (ENKTCL): A Global
Study of the PETAL (PEripheral
T-Cell Lymphoma) Consortium
Presented by Alexandra Lenart
Integrated Omics to Dissect the Landscape in Chemosensitive and Refractory Extranodal Natural-Killer T-Cell Lymphoma (ENKTCL): A Global Study of the PETAL (Peripheral T-Cell Lymphoma)Consortium
Presented by Alexandra Lenart
Real-World Evidence of Duvelisib and Romidepsin Combination
in Relapsed/Refractory (R/R) Peripheral and Cutaneous T-Cell Lymphomas Presented by Kusha Chopra
Real-World Evidence of Duvelisib and
Romidepsin Combination in Relapsed/
Refractory (R/R) Peripheral and Cutaneous
T-Cell Lymphomas
Presented by Kusha Chopra
Real-World Evidence of Duvelisib and Romidepsin Combination
in Relapsed/Refractory (R/R) Peripheral and Cutaneous T-Cell Lymphomas Presented by Kusha Chopra
Integrated Omics to Dissect the Landscape in Chemosensitive and Refractory Extranodal Natural-Killer T-Cell Lymphoma (ENKTCL): A Global Study of the PETAL (Peripheral T-Cell Lymphoma) Consortium, Presented by: Sean M McCabe
Integrated Omics to Dissect the
Landscape in Chemosensitive and
Refractory Extranodal Natural-Killer
T-Cell Lymphoma (ENKTCL): A Global
Study of the PETAL (Peripheral T-Cell
Lymphoma) Consortium, Presented
by: Sean M McCabe
Integrated Omics to Dissect the Landscape in Chemosensitive and Refractory Extranodal Natural-Killer T-Cell Lymphoma (ENKTCL): A Global Study of the PETAL (Peripheral T-Cell Lymphoma) Consortium, Presented by: Sean M McCabe
Integrative analysis of 3D chromatin organization reveals regulation mechanisms in angioimmunoblastic T-cell lymphoma, Presented by: Caroline MacVicar
Integrative analysis of 3D chromatin
organization reveals regulation
mechanisms in angioimmunoblastic
T-cell lymphoma,
Presented by: Caroline MacVicar
Molecular Residual Disease Detection via CAPP-Seq in Patients with PTCL Undergoing Autologous Stem Cell Transplantation, Presented by: Josie Ford
Molecular Residual Disease Detection
via CAPP-Seq in Patients with PTCL
Undergoing Autologous Stem Cell
Transplantation,
Presented by: Josie Ford
Real-World Evidence for Duvelisib and Romidepsin Combination in Patients with Relapsed/Refractory (R/R) Peripheral T-cell Lymphoma, Presented by: Josie Ford
Real-World Evidence for Devlisib and
Romidepsin Combination in Patients
with Relapsed/Refractory (R/R)
Peripheral T-cell Lymphoma,
Presented by: Josie Ford
For Healthcare Professionals
@2025 PETAL Consortium • All rights reserved
For Healthcare Professionals
@2025 PETAL Consortium • All rights reserved